293 T cells) was used for the production and characterization of LVs (both research grade and GMP grade). A fully characterized 293 T-based master cell bank was established at Cell and Gene Therapy at King’s (King’s College London, London, UK). FEMX-I (...
As the field moves towards definitive late stage trials, with a growing interest from pharmaceutical companies, we realize that novel cell therapy strategies pose questions that are familiar to traditional drug development, along with new considerations due to the potential of T cells to persist long...
1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; 2Department of Hematological Medicine, Cell and Gene Therapy at King's, The Rayne Institute, King's College London, London, UK; 3Department of Dermatology and Allergy, Skin ...